Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)

NCT01373398 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: EO9(Apaziquone)

Sponsor

Handok Inc.